• Nanoparticle PTEN mRNA Delivery Reverses Trastuzumab Resista

  2026-07-16

  The reference study demonstrates that tumor microenvironment-responsive nanoparticles can systemically deliver PTEN mRNA to HER2-positive breast tumors, restoring PTEN function and reversing resistance to trastuzumab. This approach provides a mechanistically rational strategy for overcoming PI3K/Akt-driven therapy resistance in breast cancer.

• CORE LNPs Enable Selective Splenic mRNA Delivery via Cholest

  2026-07-16

  This study presents CORE lipid nanoparticles (LNPs) with structurally modified cholesterol analogs to achieve targeted mRNA expression in the spleen, overcoming the common hepatic tropism of standard LNPs. The findings highlight a rational, computationally guided approach for extrahepatic mRNA delivery, with implications for vaccines and immune therapies.

• Olsalazine Sodium in Cancer and Inflammation Research Workfl

  2026-07-15

  Olsalazine Sodium stands out as a potent mesalamine dimer for both cancer and inflammation models, enabling precise LTB4 chemotaxis inhibition and xenobiotic transport studies. This guide details validated workflows, troubleshooting strategies, and protocol optimizations for maximizing reproducibility, with insights drawn from recent advances in mosquito physiology and colorectal cancer research.

• Hydrocortisone in Translational Research: Workflows & Advanc

  2026-07-15

  Hydrocortisone stands out as a gold-standard glucocorticoid hormone for dissecting inflammation, stress response, and neuroprotection in both cellular and animal models. This article translates cutting-edge findings and real-world troubleshooting into actionable, reproducible workflows for researchers seeking robust, data-driven results.

• Helper-Polymer FNPs Enable Stable, Lung-Targeted mRNA Delive

  2026-07-14

  The referenced study introduces five-element nanoparticles (FNPs) incorporating poly(β-amino esters) (PBAEs) and DOTAP for lung-specific mRNA delivery with unprecedented stability after lyophilization. This innovation addresses major bottlenecks in mRNA therapeutic storage and delivery, with implications for expanding access and improving the practicality of mRNA-based treatments for pulmonary diseases.

• FAISL lncRNA Blocks FAK Proteolysis, Driving TNBC Progressio

  2026-07-14

  The referenced study uncovers a novel mechanism in triple negative breast cancer (TNBC) where the long noncoding RNA FAISL stabilizes FAK protein by blocking Calpain 2-mediated proteolysis, thereby promoting tumor progression and metastasis. These findings highlight FAISL as both a crucial regulator of FAK and a potential therapeutic target in aggressive breast cancers.

• PEGylated mRNA Lipoplexes for Tumor Vaccination: Efficacy an

  2026-07-13

  This study introduces a PEGylated mRNA lipoplex platform optimized for intravenous tumor vaccination, demonstrating robust antibody and cytotoxic T cell responses while minimizing off-target lung accumulation. The findings advance design principles for safer and more effective mRNA delivery systems in cancer immunotherapy.

• Aptamer-LNPs Enable Targeted PTEN mRNA Delivery in Prostate

  2026-07-13

  This study presents a lipid nanoparticle (LNP) platform conjugated with a PD-L1-targeting DNA aptamer for precise delivery of PTEN mRNA to prostate cancer cells. By restoring PTEN function and downregulating the PI3K/AKT pathway, the approach significantly inhibits tumor growth and demonstrates a promising step toward gene therapy for castration-resistant prostate cancer.

• CH 223191: Precision AhR Antagonist for Toxicology & Regener

  2026-07-12

  CH 223191 stands out as a gold-standard aryl hydrocarbon receptor antagonist, empowering researchers to dissect the AhR signaling pathway in environmental toxicology and regenerative biology. This guide delivers actionable workflows, troubleshooting strategies, and translational insights, leveraging recent breakthroughs linking microbiota metabolism, AhR activity, and tissue repair.

• Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho

  2026-07-10

  This study reveals that certain p38α MAPK inhibitors not only block kinase activity, but also promote dephosphorylation of the activation loop by stabilizing conformations accessible to phosphatases. These dual-action effects suggest new strategies for enhancing selectivity and potency in kinase-targeted inflammation research.

• Caspase-3 Fluorometric Assay Kit: Decoding Apoptosis-Ferropt

  2026-07-09

  Explore how the Caspase-3 Fluorometric Assay Kit empowers precise, quantitative detection of cysteine-dependent aspartate-directed protease activity and unlocks new insights into apoptosis-ferroptosis interplay. This article bridges cutting-edge mechanistic research with practical assay strategy.

• MLN8237 (Alisertib): Applied Protocols in Cancer Biology Res

  2026-07-09

  MLN8237 (Alisertib) empowers researchers to dissect Aurora A kinase’s oncogenic role and to induce apoptosis with high selectivity in vitro and in vivo. This guide translates recent retinoblastoma breakthroughs into actionable workflows, troubleshooting strategies, and protocol enhancements tailored for cancer biology labs.

• SlSLAH1–SlSTOP1 Pathway Enables Aluminium Tolerance in Tomat

  2026-07-08

  This study identifies the plasma membrane anion channel SlSLAH1 as the key mediator of aluminium (Al) tolerance in tomato roots, directly regulated by the SlSTOP1-SlSZP1 transcriptional complex. The findings elucidate how malate exudation is controlled at the molecular level, offering evidence-based strategies for engineering Al-tolerant crops.

• RepSox ALK5 Inhibitor: Enhancing iPSC Platelet Differentiati

  2026-07-08

  RepSox, a potent and selective ALK5 inhibitor, is redefining induced pluripotent stem cell (iPSC) workflows by enabling cost-effective, high-yield platelet production. This article translates bench research into practical protocols, troubleshooting tips, and comparative insights for regenerative medicine and cell therapy applications.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): P

  2026-07-07

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) address the challenge of high-specificity capture of biotinylated molecules from complex samples, facilitating workflows such as protein and nucleic acid purification, immunoprecipitation, and phage display. These beads are not intended for applications requiring covalent immobilization or for use with non-biotinylated targets.

16253 records 1/1084 page Next 12345 下5页 Last page